Clinical Trial Update: Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study [Phase 2]

View source ↗

Summary

Clinical trial update on the TRAIN-3 Phase 2 study evaluating image-guided de-escalation of neoadjuvant chemotherapy in HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Borstkanker Onderzoek Groep | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING